September 2020
Medical Affairs Strategic Summit West
San Diego, CA
2019 Highlights
- Establishing strong collaborative partnerships with R&D and commercial colleagues to drive scientific impact ahead of a launch
- Developing processes and actions to ensure compliance with company policies
- Utilizing field insights to develop a comprehensive medical strategy
- Identifying key value–drivers and outcomes that can impact economic and payer-related communications
Snapshot of 2019 Speakers
Diana Stefani-Hunyady,
M.D., Ph.D., MBA,
Head of Medical Medical Affairs
VIELA BIO
Michael J.Breen, O.D.,
Head, Medical Science — Surgical and Vision Care
ALCON
Matthew J Maneen, Ph.D
Senior Director and Head of U.S. Field Medical
AVANIR PHARMACEUTICALS
Christina Costantino
Ph.D., MBA, Senior Global Scientific Director
GENENTECH
Matthew D. Bryant, Pham.D,
Vice President, Global Medical Affairs,
EIGER BIOPHARMACEUTICALS
Leslie Meltzer, Ph.D.,
Vice President, Medical Affairs
ORCHARD THERAPEUTICS
Tony Russel
Senior Director, Product Strategy and Commercial Planning
THERAVANCE BIOPHARMA
Carol Hoang, Pharm.D., MBA
Vice President Medical Affairs
ADVERUM BIOTECHNOLOGIES
WHO ATTENDS
This conference is designed for professionals from pharmaceutical, biotechnology, and medical device companies with job responsibilities including:
|
Medical Affairs/Field Medical Affairs Medical/Science liaisons/MSLs Clinical/Scientific Affairs Medical Strategy/Communications Medical/Clinical Operations KOL/Thought Leader Relations/Engagement Investigator-Initiated Research ( IIR) Investigator-Initiated Studies (IIS) Investigator-Initiated Trials Investigator-Sponsored Trials (IST) Research Collaborations |
Medical/Scientific/Patient Communications Medical Information Medical Education Publication Planning Health Economics and Outcomes Research/HEO Compliance/Legal Regulatory Affairs Research Grants Patient Services Clinical Outcomes and Publications |